Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG.
about
Second-generation inhibitors of Bruton tyrosine kinaseNew development in CAR-T cell therapy.Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALLDiagnosis and treatment of CD20 negative B cell lymphomas.Syk inhibitors in clinical development for hematological malignancies.
P2860
Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@en
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@nl
type
label
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@en
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@nl
prefLabel
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@en
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@nl
P2093
P2860
P1476
Complete remission after singl ...... arabine mitoxantrone and CLAG.
@en
P2093
Deepthi Gandhiraj
Delong Liu
Karen Seiter
Katherine Linder
Madhura Hanmantgad
P2860
P2888
P356
10.1186/S40164-016-0051-4
P577
2015-01-01T00:00:00Z
P6179
1045646609